Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Pharm Res ; 29(8): 2035-46, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22422320

ABSTRACT

PURPOSE: To determine the extent of lateral spread and stratum corneum (SC) penetration of caffeine (CAF), hydrocortisone (HC) and ibuprofen (IBU) using a novel concentric tape stripping technique. METHOD: Ethanolic solutions of CAF, HC or IBU were applied to the forearm of 8 volunteers. At various time points, 10 successive layers of SC were removed by stripping with tapes perforated into concentric rings and analysed for drug concentration and mass of SC protein. In vitro permeation studies assessed the percutaneous absorption of these compounds across human skin. RESULTS: CAF and IBU showed significant lateral spreading across the SC while HC formed a drug depot at the site of application. Relative to the applied dose, the in vivo recovery of all compounds from the combined 10 strips at 3 mins ranged between 83.0 and 92.9 % and decreased to between 64.5 and 66.9 % at 3 h. IBU recovery further decreased to 47.7 ± 5.6 % at 6 h, correlating with greater in vitro penetration relative to CAF and HC. CONCLUSION: Drug concentration decreased with increased lateral distance from the application site. The lower recovery of IBU in the upper tape strip regions compared to CAF and HC may be a consequence of greater penetration into the SC with time.


Subject(s)
Analgesics, Non-Narcotic/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Caffeine/administration & dosage , Central Nervous System Stimulants/administration & dosage , Drug Delivery Systems/instrumentation , Epidermis/metabolism , Hydrocortisone/administration & dosage , Ibuprofen/administration & dosage , Adhesives/chemistry , Administration, Topical , Adult , Analgesics, Non-Narcotic/pharmacokinetics , Anti-Inflammatory Agents/pharmacokinetics , Caffeine/pharmacokinetics , Central Nervous System Stimulants/pharmacokinetics , Female , Humans , Hydrocortisone/pharmacokinetics , Ibuprofen/pharmacokinetics , Male , Skin Absorption , Young Adult
2.
J Pharm Sci ; 94(3): 632-8, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15666298

ABSTRACT

In vitro measurements of skin absorption are an increasingly important aspect of regulatory studies, product support claims, and formulation screening. However, such measurements are significantly affected by skin variability. The purpose of this study was to determine inter- and intralaboratory variation in diffusion cell measurements caused by factors other than skin. This was attained through the use of an artificial (silicone rubber) rate-limiting membrane and the provision of materials including a standard penetrant, methyl paraben (MP), and a minimally prescriptive protocol to each of the 18 participating laboratories. "Standardized" calculations of MP flux were determined from the data submitted by each laboratory by applying a predefined mathematical model. This was deemed necessary to eliminate any interlaboratory variation caused by different methods of flux calculations. Average fluxes of MP calculated and reported by each laboratory (60 +/- 27 microg cm(-2) h(-1), n = 25, range 27-101) were in agreement with the standardized calculations of MP flux (60 +/- 21 microg cm(-2) h(-1), range 19-120). The coefficient of variation between laboratories was approximately 35% and was manifest as a fourfold difference between the lowest and highest average flux values and a sixfold difference between the lowest and highest individual flux values. Intralaboratory variation was lower, averaging 10% for five individuals using the same equipment within a single laboratory. Further studies should be performed to clarify the exact components responsible for nonskin-related variability in diffusion cell measurements. It is clear that further developments of in vitro methodologies for measuring skin absorption are required.


Subject(s)
Clinical Laboratory Techniques/standards , Observer Variation , Clinical Laboratory Techniques/statistics & numerical data , Diffusion , Diffusion Chambers, Culture/methods , Diffusion Chambers, Culture/standards , Diffusion Chambers, Culture/statistics & numerical data , Internationality , Quality Control , Reference Standards , Reference Values , Skin Absorption/physiology
3.
Int J Pharm ; 271(1-2): 5-10, 2004 Mar 01.
Article in English | MEDLINE | ID: mdl-15129968

ABSTRACT

Differential scanning calorimetry (DSC) was used to investigate the mechanism of action of a proprietary skin penetration enhancer, dodecyl-2-(N,N-dimethylamino)propionate (DDAIP) in dipalmitoylphosphatidylcholine (DPPC) liposomes. Furthermore, the effect of enhancer concentration on lipid thermotropic transitions was investigated. With increasing concentrations of DDAIP (from 5 to 50 mol%), the main transition peak shifted to lower temperatures and became more broad. The pretransition peak also shifted to lower temperatures with increasing concentrations of DDAIP and disappeared completely above an enhancer concentration of 20 mol%. Main transition and pretransition enthalpies of reaction decreased with increasing DDAIP concentration, indicating that enhancer treatment destabilized both rippled gel and liquid crystal phases within the bilayer. At and above a DDAIP concentration of 33.3 mol%, an additional transition was evident, indicating the presence of two phases of enhancer-lipid complex. Results suggest that DDAIP enhances drug transport by interacting with the polar region of the phospholipid bilayer and also by increasing the motional freedom of lipid hydrocarbon chains.


Subject(s)
1,2-Dipalmitoylphosphatidylcholine/chemistry , Alanine/analogs & derivatives , Alanine/chemistry , Lipid Bilayers/chemistry , Calorimetry, Differential Scanning , Dose-Response Relationship, Drug , Gels , Liposomes , Phase Transition , Temperature
5.
J Pharm Sci ; 87(10): 1213-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9758679

ABSTRACT

The feasibility of using some novel topical spray vehicles for enhanced transdermal delivery of the sex hormones, testosterone (Tes), estradiol (E2), progesterone (Prog), and norethindrone acetate (NA) has been investigated. The new penetration enhancers, padimate O (PadO) and octyl salicylate (OSal) were used and compared with laurocapram (AZ) and oleic acid (OA). A finite dose (5 microL/cm2) of each vehicle was applied to either shed snake skin or swine skin in vitro, and the amount penetrated was measured with flow-through diffusion cells. Partitioning into swine skin was determined after an exposure time of 1 min. Rapid partitioning of Tes and PadO into swine skin occurred after 1 min with 70% and 60% of the applied dose, respectively, remaining in the skin after the unabsorbed dose was removed by rinsing with absolute ethanol. The cumulative amount at 24 h (Q24 h) of Tes penetrating across the snake skin was significantly enhanced (p < 0.05) up to 6-fold for OSal, 3-fold for OA and AZ, and 2-fold for PadO compared to control. Using PadO or AZ, the Q24 h ranged from three- to thirteen-fold over control (p < 0.05) for E2, Prog, and NA. Extrapolation of these data to predict what would happen in humans suggests that it should be possible to deliver clinically relevant amounts of sex hormones in this manner with once daily dosing.


Subject(s)
Gonadal Steroid Hormones/administration & dosage , Skin Absorption/drug effects , 4-Aminobenzoic Acid/pharmacology , Administration, Cutaneous , Animals , Chromatography, High Pressure Liquid , Diffusion , Gonadal Steroid Hormones/pharmacokinetics , Models, Biological , Salicylates/pharmacology , Snakes , Swine , para-Aminobenzoates
6.
J Pharm Sci ; 87(10): 1219-25, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9758680

ABSTRACT

This study investigated the enhanced transdermal delivery of testosterone (Tes) and estradiol (E2) in swine in vivo with novel metered-dose topical aerosols containing the penetration enhancer padimate O (PadO) and predicted the dose deliverable in humans from the calculated drug flux across the skin. Weanling swine were catheterized and castrated under general anaesthesia and used as a conscious hypogonadal model. Tes and E2 (with and without PadO) were applied once, and venous blood samples were taken over 24 h. Tes and E2 plasma levels were determined by radioimmunoassay. After daily topical dosing of Tes for 6 days, the plasma Tes levels were determined and the transdermal flux was calculated by correcting the pseudo steady-state plasma concentration versus time profile with the clearance of an iv dose within the same swine. After a single application of the E2 aerosol over 30 cm2, or the Tes aerosol over 180 cm2, the mean AUC0-24 h when PadO was included in the spray was 14.1- and 2.0-fold greater than control, respectively (p < 0.03). After the sixth application of the Tes spray with PadO, the mean flux (+/-SE, n = 4) across swine skin in vivo was 2.12 +/- 0.35 microg/cm2.h, which gave a predicted flux in humans of 0.95 microg/cm2.h. From these data the expected plasma levels of Tes in hypogonadal men would compare well with the normal diurnal Tes profile in healthy men. These novel topical aerosols are capable of enhanced transdermal delivery of sex hormones in vivo, and they have the potential to deliver clinically relevant doses to humans.


Subject(s)
Gonadal Steroid Hormones/administration & dosage , Administration, Cutaneous , Aerosols , Animals , Area Under Curve , Male , Swine , para-Aminobenzoates
7.
J Pharm Sci ; 87(10): 1226-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9758681

ABSTRACT

The objective of this study was to determine if a novel metered-dose topical aerosol (MDTA) formulation containing the new dermal penetration enhancer, padimate O, could enhance the transdermal delivery of estradiol to an extent that would result in clinically relevant plasma concentrations. The estradiol MDTA (with padimate O) was applied once daily at 0800 h to postmenopausal women for 9 days, and plasma estradiol and estrone was measured daily (24 h postapplication) by radioimmunoassay. The topical dose was administered as three 1 mg doses of estradiol, each applied as a single spray over 10 cm2 which were placed adjacent to each other on the subject's ventral forearm. None of the subjects tested showed any sign of skin irritation at the application site over the entire study period using the Draize irritation score. In four postmenopausal women (age 54-63 years, weight 67-93 kg) the mean estradiol level 24 h postapplication over the 9 day study period was 53 pg/mL. This result was significantly greater (p < 0.001) than the baseline value of 13 pg/mL. The mean estradiol/estrone ratio also rose significantly (p < 0.04) from a baseline value of 0.2 up to 0.8. We conclude that this novel MDTA formulation significantly enhances the transdermal delivery of estradiol to allow a clinically relevant dose of estradiol to be delivered in postmenopausal women with once daily dosing.


Subject(s)
Estradiol/administration & dosage , Hormone Replacement Therapy , Postmenopause , 4-Aminobenzoic Acid/pharmacology , Aerosols , Aged , Estradiol/blood , Estrone/blood , Female , Humans , Middle Aged , Radioimmunoassay , Skin Absorption/drug effects , para-Aminobenzoates
8.
Res Vet Sci ; 63(1): 23-7, 1997.
Article in English | MEDLINE | ID: mdl-9368952

ABSTRACT

The pharmacokinetics of von Willebrand factor antigen (vWf:Ag) and factor VIII coagulant (FVIII:C) activity in dogs with von Willebrand Disease (vWD) and haemophilia A, respectively, were assessed after the administration of fresh frozen plasma (FFP) and cryoprecipitate. Loading doses necessary to attain target plasma concentrations of each factor were estimated to be 63 U kg-1 BW for FFP and 13 U kg-1 BW for cryoprecipitate to reach 35 U dl-1 vWf:Ag in vWD and 23 U kg-1 BW for FFP and 4 U kg-1 BW for cryoprecipitate to reach 30 U dl-1 FVIII:C in haemophilia A. The estimated volumes of FFP required to attain these target concentrations (49 ml kg-1 BW for vWD and 20 ml kg-1 BW for haemophilia A) are approximately 10-fold higher than the volumes of cryoprecipitate required (4 ml kg-1 BW for vWD and 2 ml kg-1 BW for haemophilia A). This indicates that cryoprecipitate is a more efficient and practical means of treating or preventing haemorrhage in these two haemostatic disorders.


Subject(s)
Dog Diseases/metabolism , Factor VIII/pharmacokinetics , Hemophilia A/veterinary , von Willebrand Diseases/veterinary , von Willebrand Factor/pharmacokinetics , Animals , Antigens/blood , Blood Coagulation/physiology , Dog Diseases/blood , Dog Diseases/physiopathology , Dogs , Factor VIII/analysis , Factor VIII/metabolism , Female , Hemophilia A/blood , Hemophilia A/metabolism , Hemorrhage/prevention & control , Hemorrhage/veterinary , Male , Plasma/physiology , von Willebrand Diseases/blood , von Willebrand Diseases/metabolism , von Willebrand Factor/analysis , von Willebrand Factor/metabolism
9.
Pharm Res ; 8(9): 1144-50, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1838597

ABSTRACT

The steady-state flux (SSF) of nicotinamide from an aqueous donor phase across a model Silastic membrane did not increase proportionally with increasing donor phase concentration. The suspected self-association of the drug in aqueous solution was evaluated by studying the concentration-dependent changes in (i) the molal osmotic coefficient of nicotinamide (freezing-point depression studies) and (ii) the partition coefficient between water and n-octanol. The freezing points of aqueous solutions of nicotinamide were measured and a plot of osmolality vs molality was nonlinear. The partition coefficient of nicotinamide, studied at 15, 25, and 32 degrees C, also decreased with increasing concentration of drug. Mathematical models describing dimerization and higher orders of association were applied to the data. The results indicated the involvement of higher orders of association and it was found that an isodesmic (step-association) model was an adequate description of the freezing-point depression and partition coefficient data. The association constant, K, ranged between 1.59 +/- 0.02 M-1 at the freezing point and 0.48 +/- 0.01 M-1 as estimated from the partition coefficient data at 32 degrees C. These models for the self-association of nicotinamide allowed estimation of the apparent concentration of "monomeric" nicotinamide in the donor phase solutions studied in the SSF experiments. When the SSF data were analyzed with regard to the concentration of monomeric nicotinamide in the donor phase, a relationship close to linearity was observed.


Subject(s)
Niacinamide/chemistry , Administration, Cutaneous , Carbon Radioisotopes , Freezing , In Vitro Techniques , Niacinamide/administration & dosage , Osmolar Concentration , Silicone Elastomers/chemistry , Solutions
11.
J Chromatogr ; 388(2): 389-96, 1987 Feb 13.
Article in English | MEDLINE | ID: mdl-3558655

ABSTRACT

A method for characterization of the melanin biopolymer has been developed and validated by the use of synthetic melanins derived from tyrosine, dopamine or hydroquinone. The technique involved pyrolysis gas-liquid chromatography with capillary columns. A back-flushing technique is described which improves pyrogram reproducibility such that closely related melanins can be distinguished with the aid of principal components analysis and non-metric multidimensional scaling.


Subject(s)
Biopolymers/analysis , Macromolecular Substances/analysis , Melanins/analysis , Chromatography, Gas , Models, Biological
SELECTION OF CITATIONS
SEARCH DETAIL
...